Beyond inpatient and outpatient care: alternative model for hypertension management

Ho, P. Michael; Rumsfeld, John S.
January 2006
BMC Public Health;2006, Vol. 6 Issue 1, p257
Academic Journal
Hypertension is a major contributor to worldwide cardiovascular mortality, however, only one-third of patients with hypertension have their blood pressure treated to guideline recommended levels. To improve hypertension control, there may need to be a fundamental shift in care delivery, one that is population-based and simultaneously addresses patient, provider and system barriers. One potential approach is home-based disease management, based on the triad of home monitoring, team care, and patient self-care. Although there may be challenges to achieving the vision of home-based disease management, there are tremendous potential benefits of such an approach for reducing the global burden of cardiovascular disease.


Related Articles

  • Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension. Bonnet, Sébastien; Provencher, Steeve; Guignabert, Christophe; Perros, Frédéric; Boucherat, Olivier; Schermuly, Ralph Theo; Hassoun, Paul M.; Rabinovitch, Marlene; Nicolls, Mark R.; Humbert, Marc // American Journal of Respiratory & Critical Care Medicine;3/1/2017, Vol. 195 Issue 5, p583 

    No abstract available.

  • Mismanaged measures.  // Nature;4/3/2008, Vol. 452 Issue 7187, p504 

    The article discusses the effectiveness of using surrogate devices in monitoring diseases. Surrogate markers are the indirect measures of treating diseases in the clinical trial. This practice will allow the researchers to conduct easy and rapid measurements. However, clinical trials found out...

  • Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension. Lobo, Melvin D.; de Belder, Mark A.; Cleveland, Trevor; Collier, David; Dasgupta, Indranil; Deanfield, John; Kapil, Vikas; Knight, Charles; Matson, Matthew; Moss, Jonathan; Paton, Julian F. R.; Poulter, Neil; Simpson, Iain; Williams, Bryan; Caulfield, Mark J. // Heart;Jan2015, Vol. 101 Issue 1, p10 

    Resistant hypertension continues to pose a major challenge to clinicians worldwide and has serious implications for patients who are at increased risk of cardiovascular morbidity and mortality with this diagnosis. Pharmacological therapy for resistant hypertension follows guidelines-based...

  • Noteworthy.  // Pharmaceutical Representative;Apr2008, Vol. 38 Issue 4, p15 

    The article presents several medical research in the U.S. Switching to decaf may help patients with type 2 diabetes control their blood glucose levels. A new study from Pharmacopeia Inc. suggests that the ten most prescribed medications in the country are commonly confused with other similarly...

  • Arterial hypertension management with conversion enzyme inhibitors in hemodialysis patients. Costea, Andreea-Cristina; Costea, D. O.; David, Cristiana; Grasa, C. N. // Journal of Medicine & Life;Jan-Mar2010, Vol. 3 Issue 1, p67 

    By establishing the renal suppletion procedure, the patients with chronic renal failure also have an acceleration of arterial hypertension phenomena. The management of this situation calls for the understanding of the ethological mechanisms (hypervolemia by the reduction of Na excretion and high...

  • Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. Slot, Karsten Bruins; Berge, Eivind; Dorman, Paul; Lewis, Steff; Dennis, Martin; Sandercock, Peter // BMJ: British Medical Journal (International Edition);2/16/2008, Vol. 336 Issue 7640, p376 

    Objective To estimate the impact on long term survival of functional status at six months after ischaemic stroke. Design Prospective cohort study. Settings Three cohorts: Oxfordshire community stroke project, Lothian stroke register, and the first international stroke trial (in the United...

  • Hypertensive men don't live as long as normotensives, despite treatment.  // Modern Medicine;Nov98, Vol. 66 Issue 11, p25 

    Presents an abstract of the study `Survival in Treated Hypertension: Follow Up Study after Two Decades,' by O. K. Andersson, A. Almgren, B. Persson et al, published in the July 18, 1998 issue of `British Medical Journal.'

  • Five year follow-up effects of treatment of mild and moderate hypertension. Trafford, J.A.P.; Horn, C.R.; O'Neal, H.; McGonigle, R.; Halford-Maw, L.; Evans, R. // British Medical Journal (Clinical Research Edition);4/4/1981, Vol. 282 Issue 6270, p1111 

    Discusses the effects of hypertension treatment. Classification of patients with hypertension; Prevalence of mortality and morbidity on untreated patients; Justification of age-and-sex matched hypertension control by reduction morbidity; Benefits of control.

  • Do we use an ACE, an ARB, or both? What clinical trials tell us. Codario, Ronald A.; Georgi, Kristen // Patient Care;Apr2005, Vol. 39 Issue 4, p54 

    Examines the use of angiotensin converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARB) as first-line therapy for hypertension, acute myocardial infection, heart failure, renal disease and inhibition of atherosclerotic deposition. Background on several studies on the benefits...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics